Annual Cash & Cash Equivalents
$6.99 M
-$6.48 M-48.10%
December 31, 2023
Summary
- As of February 7, 2025, GLSI annual cash & cash equivalents is $6.99 million, with the most recent change of -$6.48 million (-48.10%) on December 31, 2023.
- During the last 3 years, GLSI annual cash & cash equivalents has fallen by -$21.67 million (-75.61%).
- GLSI annual cash & cash equivalents is now -75.61% below its all-time high of $28.66 million, reached on December 31, 2020.
Performance
GLSI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.82 M
-$1.40 M-19.41%
September 30, 2024
Summary
- As of February 7, 2025, GLSI quarterly cash and cash equivalents is $5.82 million, with the most recent change of -$1.40 million (-19.41%) on September 30, 2024.
- Over the past year, GLSI quarterly cash and cash equivalents has dropped by -$1.17 million (-16.70%).
- GLSI quarterly cash and cash equivalents is now -80.85% below its all-time high of $30.41 million, reached on March 31, 2021.
Performance
GLSI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GLSI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.1% | -16.7% |
| 3 y3 years | -75.6% | -16.7% |
| 5 y5 years | +8113.2% | -16.7% |
GLSI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.3% | at low | -78.6% | +5.8% |
| 5 y | 5-year | -75.6% | >+9999.0% | -80.8% | >+9999.0% |
| alltime | all time | -75.6% | >+9999.0% | -80.8% | >+9999.0% |
Greenwich LifeSciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.82 M(-19.4%) |
| Jun 2024 | - | $7.22 M(+31.2%) |
| Mar 2024 | - | $5.51 M(-21.2%) |
| Dec 2023 | $6.99 M(-48.1%) | $6.99 M(-23.6%) |
| Sep 2023 | - | $9.14 M(-16.5%) |
| Jun 2023 | - | $10.94 M(-8.1%) |
| Mar 2023 | - | $11.91 M(-11.6%) |
| Dec 2022 | $13.47 M | $13.47 M(-13.9%) |
| Sep 2022 | - | $15.64 M(-9.0%) |
| Jun 2022 | - | $17.19 M(-12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $19.74 M(-27.4%) |
| Dec 2021 | $27.20 M(-5.1%) | $27.20 M(-5.9%) |
| Sep 2021 | - | $28.91 M(-3.0%) |
| Jun 2021 | - | $29.80 M(-2.0%) |
| Mar 2021 | - | $30.41 M(+6.1%) |
| Dec 2020 | $28.66 M(>+9900.0%) | $28.66 M(+361.2%) |
| Sep 2020 | - | $6.21 M(>+9900.0%) |
| Jun 2020 | - | $6800.00(0.0%) |
| Dec 2019 | $6800.00(-92.0%) | $6800.00 |
| Dec 2018 | $85.10 K | - |
FAQ
- What is Greenwich LifeSciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Greenwich LifeSciences?
- What is Greenwich LifeSciences annual cash & cash equivalents year-on-year change?
- What is Greenwich LifeSciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Greenwich LifeSciences?
- What is Greenwich LifeSciences quarterly cash and cash equivalents year-on-year change?
What is Greenwich LifeSciences annual cash & cash equivalents?
The current annual cash & cash equivalents of GLSI is $6.99 M
What is the all time high annual cash & cash equivalents for Greenwich LifeSciences?
Greenwich LifeSciences all-time high annual cash & cash equivalents is $28.66 M
What is Greenwich LifeSciences annual cash & cash equivalents year-on-year change?
Over the past year, GLSI annual cash & cash equivalents has changed by -$6.48 M (-48.10%)
What is Greenwich LifeSciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GLSI is $5.82 M
What is the all time high quarterly cash and cash equivalents for Greenwich LifeSciences?
Greenwich LifeSciences all-time high quarterly cash and cash equivalents is $30.41 M
What is Greenwich LifeSciences quarterly cash and cash equivalents year-on-year change?
Over the past year, GLSI quarterly cash and cash equivalents has changed by -$1.17 M (-16.70%)